Progress was reversed due to an increase in mortality from external causes and stagnation for cardiovascular diseases.
Study looks at sex differences in melanoma incidence
By
HealthDay News
Sep 17, 2024
Melanoma incidence is highest on the trunk in men; incidence is historically highest on limbs in women, but recent increases were seen in truncal melanoma.
Even low-risk alcohol consumption ups mortality risk in older adults
Aug 21, 2024
High-risk drinking was tied to higher all-cause, cancer and cardiovascular mortality.
Substantial disparities seen in cancer cases, deaths among men
Aug 12, 2024
Cancer deaths are projected to almost double by 2050, with more than two-fold increase for older men and low- and medium Human Development Index countries.
Mental health utilization increased around time of prostate cancer diagnosis
Aug 16, 2024
An increase was seen for both psychotropic medication and mental health service use.
Baseline MRI PI-RADS linked to biopsy reclassification in prostate cancer
Aug 14, 2024
The baseline MRI PI-RADS score was significantly linked to early biopsy reclassification for those with low-risk or favorable intermediate-risk cancer.
FDA approves another blood test for colon cancer screening
Jul 29, 2024
Currently, colonoscopy is the gold standard test for colon cancer, but adherence to it is low because it is invasive and preparation for the test is daunting.
Blood test results can enhance assessment of cancer risk
Aug 09, 2024
In men and women aged 60 years and older the positive predictive value for cancer exceeded the 3% risk threshold used by the UK National Institute for Health and Care Excellence for recommending urgent...
Study looks at effects of reducing intake of processed meat, unprocessed red meat
Jul 29, 2024
A 30% reduction in processed meat intake would lead to 352,900 fewer occurrences of type 2 diabetes and 92,500 fewer occurrences of cardiovascular disease.
AI chatbots can generate quality, empathetic, readable responses
May 17, 2024
Chatbots can generate quality responses to cancer patient questions, comparable to physician responses.